Changes in inflammatory biomarkers when switching from from 3-drug regimens to dolutegravir plus lamivudine in people living with HIV

Changes in Inflammatory and Atherogenesis Biomarkers With the 2-Drug Regimen Dolutegravir Plus Lamivudine in Antiretroviral Therapy–Experienced, Virologically Suppressed People With HIV-1: A Systematic Literature Review

(2022) Josep M Llibre et al.   Open Forum Infectious Diseases

Immunomodulatory and Anti-Inflammatory Strategies to Reduce Comorbidity Risk in People with HIV

(2020) Aaren Kettelhut et al.   Current HIV/AIDS Reports

Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV Suppression

(2016) Jose R. Castillo-Mancilla et al.   CLINICAL INFECTIOUS DISEASES

The effect of short-course antiretroviral therapy initiated in primary HIV-1 infection on interleukin-6 and D-dimer levels

(2015) Elizabeth Hamlyn et al.   AIDS

Systemic Effects of Inflammation on Health during Chronic HIV Infection

(2013) Steven G. Deeks et al.   IMMUNITY

Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection

(2008) Lewis H Kuller et al.   PLOS MEDICINE